Literature DB >> 20847057

Identification of the NC1 domain of {alpha}3 chain as critical for {alpha}3{alpha}4{alpha}5 type IV collagen network assembly.

Valerie LeBleu1, Malin Sund, Hikaru Sugimoto, Gabriel Birrane, Keizo Kanasaki, Elizabeth Finan, Caroline A Miller, Vincent H Gattone, Heather McLaughlin, Charles F Shield, Raghu Kalluri.   

Abstract

The network organization of type IV collagen consisting of α3, α4, and α5 chains in the glomerular basement membrane (GBM) is speculated to involve interactions of the triple helical and NC1 domain of individual α-chains, but in vivo evidence is lacking. To specifically address the contribution of the NC1 domain in the GBM collagen network organization, we generated a mouse with specific loss of α3NC1 domain while keeping the triple helical α3 chain intact by connecting it to the human α5NC1 domain. The absence of α3NC1 domain leads to the complete loss of the α4 chain. The α3 collagenous domain is incapable of incorporating the α5 chain, resulting in the impaired organization of the α3α4α5 chain-containing network. Although the α5 chain can assemble with the α1, α2, and α6 chains, such assembly is incapable of functionally replacing the α3α4α5 protomer. This novel approach to explore the assembly type IV collagen in vivo offers novel insights in the specific role of the NC1 domain in the assembly and function of GBM during health and disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20847057      PMCID: PMC3009915          DOI: 10.1074/jbc.M110.149534

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

1.  Crystal structure of NC1 domains. Structural basis for type IV collagen assembly in basement membranes.

Authors:  Munirathinam Sundaramoorthy; Muthuraman Meiyappan; Parvin Todd; Billy G Hudson
Journal:  J Biol Chem       Date:  2002-04-22       Impact factor: 5.157

2.  Quaternary organization of the goodpasture autoantigen, the alpha 3(IV) collagen chain. Sequestration of two cryptic autoepitopes by intrapromoter interactions with the alpha4 and alpha5 NC1 domains.

Authors:  Dorin-Bogdan Borza; Olga Bondar; Parvin Todd; Munirathinam Sundaramoorthy; Yoshikazu Sado; Yoshifumi Ninomiya; Billy G Hudson
Journal:  J Biol Chem       Date:  2002-08-21       Impact factor: 5.157

3.  Mutational analysis of type IV collagen alpha5 chain, with respect to heterotrimer formation.

Authors:  Takehiro Kobayashi; Toshio Kakihara; Makoto Uchiyama
Journal:  Biochem Biophys Res Commun       Date:  2007-12-18       Impact factor: 3.575

4.  The NC1 domain of collagen IV encodes a novel network composed of the alpha 1, alpha 2, alpha 5, and alpha 6 chains in smooth muscle basement membranes.

Authors:  D B Borza; O Bondar; Y Ninomiya; Y Sado; I Naito; P Todd; B G Hudson
Journal:  J Biol Chem       Date:  2001-05-25       Impact factor: 5.157

5.  The 1.9-A crystal structure of the noncollagenous (NC1) domain of human placenta collagen IV shows stabilization via a novel type of covalent Met-Lys cross-link.

Authors:  Manuel E Than; Stefan Henrich; Robert Huber; Albert Ries; Karlheinz Mann; Klaus Kühn; Rupert Timpl; Gleb P Bourenkov; Hans D Bartunik; Wolfram Bode
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-14       Impact factor: 11.205

6.  X-linked Alport syndrome: natural history in 195 families and genotype- phenotype correlations in males.

Authors:  Jean Philippe Jais; Bertrand Knebelmann; Iannis Giatras; Mario DE Marchi; Gianfranco Rizzoni; Alessandra Renieri; Manfred Weber; Oliver Gross; Kai-Olaf Netzer; Frances Flinter; Yves Pirson; Christine Verellen; Jörgen Wieslander; Ulf Persson; Karl Tryggvason; Paula Martin; Jens Michael Hertz; Cornelis Schröder; Marek Sanak; Sarka Krejcova; Maria Fernanda Carvalho; Juan Saus; Corinne Antignac; Hubert Smeets; Marie Claire Gubler
Journal:  J Am Soc Nephrol       Date:  2000-04       Impact factor: 10.121

7.  COL4A3/COL4A4 mutations: from familial hematuria to autosomal-dominant or recessive Alport syndrome.

Authors:  Ilaria Longo; Paola Porcedda; Francesca Mari; Daniela Giachino; Ilaria Meloni; Carla Deplano; Alfredo Brusco; Maurizio Bosio; Laura Massella; Giancarlo Lavoratti; Dario Roccatello; Giovanni Frascá; Gianna Mazzucco; Andrea Onetti Muda; Maura Conti; Federica Fasciolo; Christelle Arrondel; Laurence Heidet; Alessandra Renieri; Mario De Marchi
Journal:  Kidney Int       Date:  2002-06       Impact factor: 10.612

8.  X-linked Alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to 195 families: a "European Community Alport Syndrome Concerted Action" study.

Authors:  Jean Philippe Jais; Bertrand Knebelmann; Iannis Giatras; Mario De Marchi; Gianfranco Rizzoni; Alessandra Renieri; Manfred Weber; Oliver Gross; Kai-Olaf Netzer; Frances Flinter; Yves Pirson; Karin Dahan; Jörgen Wieslander; Ulf Persson; Karl Tryggvason; Paula Martin; Jens Michael Hertz; Cornelis Schröder; Marek Sanak; Maria Fernanda Carvalho; Juan Saus; Corinne Antignac; Hubert Smeets; Marie Claire Gubler
Journal:  J Am Soc Nephrol       Date:  2003-10       Impact factor: 10.121

9.  A human-mouse chimera of the alpha3alpha4alpha5(IV) collagen protomer rescues the renal phenotype in Col4a3-/- Alport mice.

Authors:  Laurence Heidet; Dorin-Bogdan Borza; Mélanie Jouin; Mireille Sich; Marie-Geneviève Mattei; Yoshikazu Sado; Billy G Hudson; Nicholas Hastie; Corinne Antignac; Marie-Claire Gubler
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

Review 10.  Basement membranes: structure, assembly and role in tumour angiogenesis.

Authors:  Raghu Kalluri
Journal:  Nat Rev Cancer       Date:  2003-06       Impact factor: 60.716

View more
  8 in total

1.  Endothelin A receptor activation on mesangial cells initiates Alport glomerular disease.

Authors:  Brianna Dufek; Daniel T Meehan; Duane Delimont; Linda Cheung; Michael Anne Gratton; Grady Phillips; Wenping Song; Shiguang Liu; Dominic Cosgrove
Journal:  Kidney Int       Date:  2016-04-27       Impact factor: 10.612

Review 2.  Goodpasture's disease: molecular architecture of the autoantigen provides clues to etiology and pathogenesis.

Authors:  Vadim Pedchenko; Roberto Vanacore; Billy Hudson
Journal:  Curr Opin Nephrol Hypertens       Date:  2011-05       Impact factor: 2.894

3.  COL4A3/COL4A4 mutations and features in individuals with autosomal recessive Alport syndrome.

Authors:  Helen Storey; Judy Savige; Vanessa Sivakumar; Stephen Abbs; Frances A Flinter
Journal:  J Am Soc Nephrol       Date:  2013-09-19       Impact factor: 10.121

Review 4.  The triple helix of collagens - an ancient protein structure that enabled animal multicellularity and tissue evolution.

Authors:  Aaron L Fidler; Sergei P Boudko; Antonis Rokas; Billy G Hudson
Journal:  J Cell Sci       Date:  2018-04-09       Impact factor: 5.285

Review 5.  Alport syndrome--insights from basic and clinical research.

Authors:  Jenny Kruegel; Diana Rubel; Oliver Gross
Journal:  Nat Rev Nephrol       Date:  2012-11-20       Impact factor: 28.314

6.  Endothelin-1 mediated induction of extracellular matrix genes in strial marginal cells underlies strial pathology in Alport mice.

Authors:  Daniel T Meehan; Duane Delimont; Brianna Dufek; Marisa Zallocchi; Grady Phillips; Michael Anne Gratton; Dominic Cosgrove
Journal:  Hear Res       Date:  2016-08-21       Impact factor: 3.208

7.  Prognostic value of glomerular collagen IV immunofluorescence studies in male patients with X-linked Alport syndrome.

Authors:  Laura Massella; Concetta Gangemi; Kostas Giannakakis; Antonella Crisafi; Tullio Faraggiana; Chiara Fallerini; Alessandra Renieri; Andrea Onetti Muda; Francesco Emma
Journal:  Clin J Am Soc Nephrol       Date:  2013-01-31       Impact factor: 8.237

8.  Type IV Collagen Controls the Axogenesis of Cerebellar Granule Cells by Regulating Basement Membrane Integrity in Zebrafish.

Authors:  Miki Takeuchi; Shingo Yamaguchi; Shigenobu Yonemura; Kisa Kakiguchi; Yoshikatsu Sato; Tetsuya Higashiyama; Takashi Shimizu; Masahiko Hibi
Journal:  PLoS Genet       Date:  2015-10-09       Impact factor: 5.917

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.